Oramed Pharmaceuticals Inc.

Regulatory Filings • Apr 14, 2019

_________ false

����� ����������� ����	2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	11706
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	13/04/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-033648	Time of broadcast: 23:53 23:52:28

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

	Delay the publication of a report	_________	_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Form 4

ORAMEDPHARMINC_4_20190412_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 19/02/2019
Address: 142 W 57th St. 11th floor 0 , New York 10019   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: EISENBERG AVIZOHAR Hilla Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Hi-Tech Park, Givat Ram 2/4 , Jerusalem 91390 Telephone: 02-5660001 Facsimile: 02-5660004 E-mail: hilla@oramed.com 2
USA